Bolt Biotherapeutics (BOLT) Price/FCF Ratio: History & Chart

Bolt Biotherapeutics, Inc.(BOLT)

Biotechnology · Redwood City, CA

$3.50+0.05 (+1.42%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

About Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics, Inc. is a biotechnology company currently conducting clinical trials, focused on developing innovative immuno-oncology therapies. Its mission is to create agents that equip the body's immune system to identify and eliminate cancerous cells. A key therapeutic in its pipeline is BDC-1001, an investigational treatment targeting the human epidermal growth factor receptor 2 (HER2). This compound is presently undergoing Phase I/II clinical evaluation for patients with HER2-positive solid tumors, including those exhibiting low HER2 expression. Beyond BDC-1001, the company is advancing several other programs: BDC-2034, which targets carcinoembryonic antigen for various indications such as colorectal, non-small cell lung, pancreatic, and breast cancers; and BDC-3042, a Dectin-2 agonist antibody designed to reprogram crucial immune cells within the tumor microenvironment by interacting with macrophage cell-surface receptors. Bolt is also pursuing a programmed cell death-ligand 1 (PD-L1) initiative aimed at addressing tumors that prove resistant to existing immune checkpoint blockades. Incorporated in 2015 under its previous name, Bolt Therapeutics, Inc., before officially becoming Bolt Biotherapeutics, Inc. in July of the same year, the company maintains its corporate headquarters in Redwood City, California.

Redwood City, CA

23 employees

www.boltbio.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: William Quinn

View full financials

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Bolt Biotherapeutics, Inc. (BOLT)	$6.72M	N/A	N/A	N/A	N/A
Aclarion, Inc. (ACON)vs ›	$6.74M	N/A	N/A	N/A	N/A
Enveric Biosciences, Inc. (ENVB)vs ›	$6.76M	N/A	2104.37	2470.51	5857.68
Co-Diagnostics, Inc. (CODX)vs ›	$6.88M	N/A	6.05	13.36	13.36
Ensysce Biosciences, Inc. (ENSC)vs ›	$6.44M	N/A	1251.36	3596.79	3596.79
Curanex Pharmaceuticals Inc Common Stock (CURX)vs ›	$7.03M	N/A	N/A	N/A	N/A
Biomerica, Inc. (BMRA)vs ›	$6.34M	N/A	129.84	129.84	129.84
InMed Pharmaceuticals Inc. (INM)vs ›	$7.31M	N/A	41006.18	41006.18	41006.18
Femasys Inc. (FEMY)vs ›	$6.10M	N/A	N/A	N/A	N/A
Cardio Diagnostics Holdings, Inc. (CDIO)vs ›	$6.10M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

PRICE/FCF RATIO

TTM

Bolt Biotherapeutics, Inc. (BOLT)

$6.72M

N/A

Aclarion, Inc. (ACON)vs ›

$6.74M

N/A

Enveric Biosciences, Inc. (ENVB)vs ›

$6.76M